Presentation is loading. Please wait.

Presentation is loading. Please wait.

Maribavir for Treatment of Cytomegalovirus Infections Resistant or Refractory to Ganciclovir or Foscarnet in Hematopoietic Stem Cell Transplant or Solid.

Similar presentations


Presentation on theme: "Maribavir for Treatment of Cytomegalovirus Infections Resistant or Refractory to Ganciclovir or Foscarnet in Hematopoietic Stem Cell Transplant or Solid."— Presentation transcript:

1 Maribavir for Treatment of Cytomegalovirus Infections Resistant or Refractory to Ganciclovir or Foscarnet in Hematopoietic Stem Cell Transplant or Solid Organ Transplant Recipients: A Randomized, Dose-Ranging, Double-Blind, Phase 2 Study  Genovefa A. Papanicolaou, Fernanda P. Silveira, Amelia A. Langston, Marcus R. Pereira, Robin K. Avery, Anna Wijatyk, Jingyang J. Wu, Michael J. Boeckh, Francisco M. Marty, Stephen Villano  Biology of Blood and Marrow Transplantation  Volume 23, Issue 3, Pages S56-S57 (March 2017) DOI: /j.bbmt Copyright © Terms and Conditions

2 Biology of Blood and Marrow Transplantation 2017 23, S56-S57DOI: (10
Biology of Blood and Marrow Transplantation  , S56-S57DOI: ( /j.bbmt ) Copyright © Terms and Conditions

3 Biology of Blood and Marrow Transplantation 2017 23, S56-S57DOI: (10
Biology of Blood and Marrow Transplantation  , S56-S57DOI: ( /j.bbmt ) Copyright © Terms and Conditions


Download ppt "Maribavir for Treatment of Cytomegalovirus Infections Resistant or Refractory to Ganciclovir or Foscarnet in Hematopoietic Stem Cell Transplant or Solid."

Similar presentations


Ads by Google